All peptidesWeight lossEducational content

Dual GIP/GLP-1 receptor agonist

Tirzepatide

A dual GIP/GLP-1 receptor agonist studied for metabolic health and weight management, prescribed through licensed telehealth clinics.

01

Overview

Tirzepatide acts on two separate gut hormone pathways involved in appetite and glucose regulation. Telehealth programs typically require an intake review, lab work, and ongoing clinician follow-up before and during treatment.

Partners

Clinics for Weight loss

Telehealth clinics editorially linked to Weight loss. A licensed clinician decides what is appropriate for you.

View category

Related articles

More reading in Weight loss

View all

Related peptides

More compounds in Weight loss — including options with live pharmacy pricing

Weight loss

Amylin-pathway peptide

Cagrilintide

An amylin-analog peptide sometimes discussed alongside GLP-1 therapies for appetite regulation, generally offered off-label or in combination programs.

Educational guide

Weight loss

Earlier-generation GLP-1 option

Liraglutide

An earlier-generation GLP-1 receptor agonist still prescribed by some telehealth providers as a metabolic health option.

Educational guide